|
WDR12 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.534400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.048400E-01 |
| Normal-vs-Stage2 |
2.856000E-01 |
| Normal-vs-Stage3 |
3.742200E-02 |
| Normal-vs-Stage4 |
1.786300E-02 |
| Stage1-vs-Stage2 |
1.726630E-01 |
| Stage1-vs-Stage3 |
6.001300E-03 |
| Stage1-vs-Stage4 |
3.639900E-03 |
| Stage2-vs-Stage3 |
3.955200E-01 |
| Stage2-vs-Stage4 |
9.842200E-02 |
| Stage3-vs-Stage4 |
4.114000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.445000E-01 |
| Normal-vs-AfricanAmerican |
7.798800E-01 |
| Normal-vs-Asian |
4.002600E-01 |
| Caucasian-vs-AfricanAmerican |
8.587000E-01 |
| Caucasian-vs-Asian |
4.373000E-01 |
| AfricanAmerican-vs-Asian |
4.243000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.811600E-01 |
| Normal-vs-Female |
1.063630E-02 |
| Male-vs-Female |
3.339800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.842600E-01 |
| Normal-vs-Extreme_Weight |
1.866590E-01 |
| Normal-vs-Obese |
5.154000E-01 |
| Normal-vs-Extreme_Obese |
3.417000E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.046100E-02 |
| Normal_Weight-vs-Obese |
7.289600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.799200E-01 |
| Extreme_Weight-vs-Obese |
1.282020E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.696000E-02 |
| Obese-vs-Extreme_Obese |
5.668600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.020500E-02 |
| Normal-vs-Age(41-60Yrs) |
4.413800E-01 |
| Normal-vs-Age(61-80Yrs) |
9.066600E-01 |
| Normal-vs-Age(81-100Yrs) |
9.791600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.630100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.883500E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.529600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.048200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.245000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.790200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.679030E-01 |
| Normal-VS-Type2 PRCC |
2.396100E-02 |
| Normal-VS-KIRP CIMP |
1.490020E-02 |
| Normal-VS-Unclassified PRCC |
5.809400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.340400E-03 |
| Type1 PRCC-VS-KIRP CIMP |
2.10239999999251E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
1.342640E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.319000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.381900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.256800E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.558200E-01 |
| Normal-vs-N1 |
4.017300E-03 |
| Normal-vs-N2 |
4.166200E-01 |
| N0-vs-N1 |
1.843540E-03 |
| N0-vs-N2 |
4.153000E-01 |
| N1-vs-N2 |
7.850400E-01 |
|
|
